Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

EPT Disclosure

14 Jun 2006 11:15

Deutsche Bank AG London14 June 2006 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Deutsche Bank AG London Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinarydealings being disclosed relate (Note 1) Date of dealing 13/06/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 25,200 £13.075 £13.07 Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)e.g. CFD CFD Long 25,000 £13.07CFD Long 200 £13.075 (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American, Date paid/received pere.g. call option varying etc. relates (Note 5) price European etc. unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. NONE Date of disclosure 14/06/2006 Contact name Kelly-Jade Ledwich Telephone number 020 7545 7804 Name of offeree/offeror with which connected AstraZeneca Plc Nature of connection (Note 6) Adviser to the offeror Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20124:04 pmRNSDividend Payment Date
6th Mar 20123:55 pmRNSAGM and SGM Results
6th Mar 20127:00 amRNSCATCo appoints Director Underwriting, Ron Collins
15th Feb 20122:06 pmRNSPublication of Supplementary Prospectus
15th Feb 20127:00 amRNSNet Asset Value(s)
10th Feb 20127:00 amRNSAnnual Financial Report 20 Dec 2010 to 31 Dec 2011
18th Jan 20127:00 amRNSCorporate Activity and portfolio deployment update
11th Jan 20125:34 pmRNSChange of Director's Details
10th Jan 20122:44 pmRNSNet Asset Value(s)
10th Jan 20121:12 pmRNS2012 Portfolio and Side Pocket Investment Update
23rd Dec 20111:01 pmRNSHolding(s) in Company
23rd Dec 20111:00 pmRNSHolding(s) in Company
23rd Dec 20111:00 pmRNSHolding(s) in Company
20th Dec 20117:00 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSHolding(s) in Company
16th Dec 20114:06 pmRNSDirectors Dealing
9th Dec 20118:43 amRNSIssue of Equity
22nd Nov 20117:00 amRNSResult of Placing
18th Nov 20114:45 pmRNSRegulation of the Investment Manager
15th Nov 201111:20 amRNSNet Asset Value, Interim Dividend announcement and
11th Nov 20119:59 amRNSPublication of Supplementary Prospectus
14th Oct 20118:35 amRNSUpdate on side pocket investments
14th Oct 20117:00 amRNSHolding(s) in Company
11th Oct 20117:00 amRNSChange of Director's details
10th Oct 20111:40 pmRNSNet Asset Value(s)
6th Oct 20118:09 amRNSBoard considering fund raising options
8th Sep 201110:27 amRNSNet Asset Value(s)
30th Aug 20112:04 pmRNSPortfolio Update - Hurricane Irene
26th Aug 20116:01 pmRNSHalf Yearly Report
19th Aug 20115:31 pmRNSHolding(s) in Company
17th Aug 20117:00 amRNSHolding(s) in Company
11th Aug 20118:55 amRNSReplacement - Net Asset Value
9th Aug 20117:00 amRNSNet Asset Value(s)
12th Jul 20119:48 amRNSNet Asset Value(s)
16th Jun 20114:44 pmRNSPortfolio Deployment Update
27th May 20111:40 pmRNSHolding(s) in Company
25th May 20116:29 pmRNSHolding(s) in Company
24th May 20118:48 amRNSIssue of Equity
23rd May 20114:20 pmRNSDirector/PDMR Shareholding
23rd May 20114:20 pmRNSDirector/PDMR Shareholding
18th May 20112:01 pmRNSC-Share Issue
17th May 20117:55 amRNSNet Asset Value(s)
16th May 20118:10 amRNSResult of Meeting
20th Apr 20112:33 pmRNSNotice of EGM and Publication of Circular
18th Apr 20117:00 amRNSPortfolio Update
11th Apr 20117:00 amRNSNet Asset Value(s)
8th Apr 20117:00 amRNSProposed Capital Raising for New Investment Opport
1st Apr 201112:00 pmRNSAppointment of non-executive director
31st Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.